Medicare Enrolled

Dr. Wayne Burkhead, M.D.

Orthopedic Surgery · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
9301 N CENTRAL EXPY STE 500, Dallas, TX 75231
2142202468
In practice since 2006 (19 years)
NPI: 1073533774 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Burkhead from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Burkhead? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Burkhead

Dr. Wayne Burkhead is an orthopedic surgery in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Burkhead performed 2,472 Medicare services across 1,719 unique beneficiaries.

Between the years covered by Open Payments, Dr. Burkhead received a total of $1,001,448 from 25 pharmaceutical and/or device companies across 166 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in orthopedic surgery. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Burkhead is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 24% volume in TX$ $1,001,448 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,472
Medicare services
Top 24% in TX for orthopedic surgery
1,719
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~130 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Shoulder X-ray, 2+ views519$24$102
Steroid injection (triamcinolone)466$1$9
Office visit, established patient (20-29 min)380$60$233
Joint injection, major joint359$49$244
Office visit, established patient (30-39 min)255$87$338
Injection, ketorolac tromethamine, per 15 mg95$0$20
Prosthetic repair of shoulder joint, total shoulder45$1,182$4,604
Office visit, established patient, complex (40-54 min)44$118$454
Partial removal of collar bone41$234$1,851
Office visit, established patient (10-19 min)34$41$141
X-ray of shoulder, 1 view32$16$66
New patient office visit (45-59 min)32$108$510
Injection of trigger points, 1-2 muscles25$35$175
Removal of extensive shoulder joint tissue using an endoscope21$316$1,987
Repair of chronic torn shoulder rotator cuff20$567$2,701
Aspiration and/or injection of fluid from medium joint18$35$181
Fluoroscopic guidance for needle placement17$83$337
Partial removal or repair of shoulder bone near collar bone16$375$1,941
Anchoring of biceps tendon16$423$2,358
Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve14$67$286
New patient office visit, complex (60-74 min)12$154$645
New patient office visit (30-44 min)11$71$334
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,001,448
Total received (2018-2024)
Avg $143,064/year across 7 years
Top 2% in TX for orthopedic surgery
25
Companies
166
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$833,936 (83.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$161,355 (16.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,158 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$213,023
2023
$216,708
2022
$166,417
2021
$144,050
2020
$136,516
2019
$94,649
2018
$30,085

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Stryker Corporation
$699,749
FX Shoulder USA, Inc
$141,502
Wright Medical Technology, Inc.
$101,513
TechMah Medical, LLC
$32,518
Limacorporate S.p.A.
$11,945
FX Shoulder Solutions, Inc
$7,498
Lima USA, Inc.
$3,174
Arthrex, Inc.
$1,603
WRIGHT MEDICAL TECHNOLOGY, INC.
$635
Pylant Medical
$401
Linvatec Corporation
$171
Horizon Therapeutics plc
$145
Anika Therapeutics, Inc.
$104
ENCORE MEDICAL, LP
$97
HydroCision, Inc.
$96
Ferring Pharmaceuticals Inc.
$64
Horizon Pharma plc
$44
DePuy Synthes Sales Inc.
$43
ERMI Inc.
$26
Zimmer Biomet Holdings, Inc.
$23
Orthofix Medical, Inc.
$23
Acacia Pharma Inc
$21
Flexion Therapeutics, Inc.
$20
Egalet US Inc
$20
Collegium Pharmaceutical, Inc.
$12
Top 3 companies account for 94.1% of total payments
Associated products mentioned in payments ›
3.5MM · AEQUALIS · AEQUALIS PERFORM · BIOBRACE 23MM · BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION · BLUEPRINT PSI SYSTEM · BYFAVO · Biomet Orthopak · CINCHLOCK · DJO Surgical Discovery Elbow System · DUEXIS · EUFLEXXA · Humelock Reversed Shoulder · INSPACE · KNOTILUS ANCHOR · MONOVISC · NO_PRODUCT · OMEGA · ORTHOLOC · ORTHOVISC · PENNSAID · Physio-Stim Osteogenesis Stimulator · Product Portfolio · SHOULDER IMPLANTS CORKSCREWS PEEK ANCHORS · SMR · SMR SHOULDER · SPRIX · Smart SPACE · SmartSpace Shoulder · Tactoset · TenJet · VIMOVO · XTAMPZA · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 2% for orthopedic surgery in TX.

Equivalent to $40,512 per 100 Medicare services performed
Looking for a orthopedic surgery in Dallas?
Compare orthopedic surgerys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse orthopedic surgerys nearby

Geographic Context

Orthopedic Surgerys within 10 mi
310
Per 100K population
11.9
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Burkhead is a clinical cardiology specialist, with above-average Medicare volume (top 24% in TX), and high industry engagement (mixed engagement, top 2%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Burkhead experienced with shoulder x-ray, 2+ views?
Based on Medicare claims data, Dr. Burkhead performed 519 shoulder x-ray, 2+ views services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Burkhead receive payments from pharmaceutical companies?
Yes. Dr. Burkhead received a total of $1,001,448 from 25 companies across 166 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Burkhead's costs compare to other orthopedic surgerys in Dallas?
Dr. Burkhead's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Burkhead) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →